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INTRODUCTION 32
Canine epilepsy studies mainly focus on the physical aspects of seizures, the impact of 33 antiepileptic drugs (AED) and more recently also behavioural changes associated with the 34 disease (Lord and Podell 1999 and severity as well as AED side effects are well described, yet the suspected impact on QoL 37 has only been studied in small numbers of affected dogs. Carers of 37 dogs with IE were mostly 38 concerned about the dog's QoL, adequate seizure frequency (less than one seizure every three 39 months) and acceptable side effects of AEDs and that these factors would determine if seizure 40 control was adequate (Chang and others 2006) . biased but with this in mind the carer can serve as surrogate. This is an accepted practice not 52 only in veterinary medicine but also in childhood epilepsy where usually the parent assesses 53 the QoL of the epileptic child (Liu and Han 2015) . It is further known that not only the QoL of 54 the affected child but also of their carer can be affected in childhood epilepsy. Parents of 55 epileptic children showed significantly lower QoL scores, and higher levels of depression and 56 4 anxiety correlating to seizure control, employment, financial implications of caring for an 57 individual with epilepsy, the occurrence of status epilepticus, drug side effects and age of 58 parents among others (Lv and others 2009 
MATERIAL AND METHODS 85
Carers of dogs diagnosed with IE were recruited at the authors' institutions (UGVS, RVC) by 86 paper mail stating a link to the online questionnaire, through contacting 800 primary care 87 practices by email and though a canine epilepsy website (www.canineepilepsy.co.uk). Data was 88 acquired from January to November 2011. Dogs were included if they presented with recurrent 89 seizures (two or more) at least one month apart which were either presumptively diagnosed 90 with IE following substantial investigation, including normal brain imaging (MRI or CT) and 91 cerebrospinal fluid analysis independent of the age of onset or strongly suspected to have IE 92 with seizures for more than one year and an age of onset between 6 months to 6 years. There was no difference in carer perceived dog's QoL scored out of ten or in the past three 162 months between dogs receiving phenobarbital or not, potassium bromide or not, or diazepam 163 or not (p>0.050). When QoL was considered since the onset of epilepsy, dogs that received 164 phenobarbital were rated by their carers to have had a reduction in QoL compared to those that 165 did not (55.6% vs. 25.7% rated their dog's QoL to be 'a little decreased' since the onset of 166 epilepsy, respectively; p=0.008), as were dogs that received potassium bromide in comparison 167 to those that did not (60.5% 'a little decreased' vs. 36.8%, respectively; p=0.017). When the 168 number of AEDs administered was considered, there was a significant difference in carer 169 perceived dog's QoL between dogs being treated with third line drugs or not, when scored out 170 of ten (Mann-Whitney= 1545, p=0.002), rated for the past 3 months categorically (X 2 = 10.8 171 p=0.013), and when questioned about how it has changed since the onset of IE (X 2 = 13.5, 172 p=0.009), with dogs receiving third line drugs having a reduced QoL compared to those that do 173 not. The severity of seven of the eleven reported AED side effects (rated from 1-5: very mildvery 201 severe) were significantly associated with carer reported acceptability of side effects (rated from 202 1-5: strongly agreestrongly disagree) at the univariate level: 'eating more', 'gaining weight', 203 'drinking more', 'urinating more', 'sleeping more', 'wobbly/not coordinated when walking' 204 and 'restlessness/pacing' (p<0.050). Increased severity of these side effects was associated with 205 10 a decreased level of carer acceptability. There was no association between the severity of 206 'itchiness/skin rash', 'vomiting', 'diarrhoea' and 'coughing' and carer-rated acceptability of 207 side effects (p>0.050). 208 209 H5: A dog's seizure frequency is associated with the degree of carer acceptability of seizure 210
frequency. 211
Seizure frequency was significantly associated with the degree of carer acceptability of seizure 212 frequency (X 2 =100.5, p<0.001), with carers reporting higher seizure frequencies disagreeing 213 more that their dogs seizure frequency was acceptable and vice versa. For example, 46.4% of 214 the carers of dogs experiencing 'less than one seizure day every six months' strongly agreed 215 their dog's seizure frequency was acceptable, whereas no carers of dogs experiencing 'more 216 than one seizure day every week' strongly agreed their dog's seizure frequency was acceptable, 217 with 75.0% strongly disagreeing. 218 219 H6: A dog's seizure severity is associated with the degree of carer acceptability of seizure 220
severity. 221
Seizure severity was significantly associated with the degree of carer acceptability of seizure 222 severity (X 2 =100.9, p<0.001), with carers reporting higher seizure severities disagreeing more 223 that their dog's seizure severity was acceptable and vice versa. For example, 37.5% of the carers 224 of dogs experiencing 'mild' seizures strongly agreed their dog's seizure severity was 225 acceptable, whereas only 4.8% of carers of dogs experiencing 'very severe' seizures strongly 226 agreed, with 61.9% strongly disagreeing that this severity was acceptable. 227
228

H7: There is an association between changes in carer QoL and carer perception of their dog's 229
QoL following the onset of IE. 230
11
There was a significant association between the change in carer perceived dog's QoL after the 231 onset of IE and the change in the carer's QoL after the onset of IE (X 2 =101.7, p<0.001), with 232 carers reporting their dog's QoL had decreased more likely to report that their QoL had 233 decreased too, and vice versa. No carers of dogs whose perceived QoL had 'much decreased' 234 after the onset of epilepsy reported their own QoL was 'increased' or 'much increased' (0.0%), 235 with 50.0% stating their QoL was also 'much decreased'. Participants commented on suffering 236 to some degree from depression or panic attacks (29.0%) and feeling isolated (22.0%) as a result 237 of caring for an epileptic dog (Supplementary file B) . In contrast, the majority (71.4%) of carers 238 who perceived their dog's QoL was 'much increased' after the onset of epilepsy reported their 239 own QoL was also 'much increased'. The AED side effects that impact on the dog's QoL and their acceptability by the carer vary 282 between the 11 investigated side effects. Only the AED side effects 'sleeping more' and the 283 severity of being 'wobbly/not coordinated when walking' significantly predicted carer 284 perception of their dog's QoL in a multivariate analysis. 'Drinking more' and 285 'restlessness/pacing' had further a significant influence on the dog's QoL at a univariate level. 286
However, increased severity of these side effects 'eating more', 'gaining weight', 'drinking 287 more', 'urinating more', 'sleeping more', 'wobbly/not coordinated when walking' and 288 'restlessness/pacing' were associated with a decreased level of carer acceptability. The variety 289 of the different side effects may explain discrepancies to previous studies. One study reported 290 that phenobarbital therapy appeared to have minimal side effects on the overall carer perceived 291
QoL of the studied dog population and thus did not produce a significant problem for the carers 292 (Lord and Podell 1999) , whereas another study reported that acceptable side effects were one 293 of the greatest concerns for carers (Chang and others 2006) . The presence of side effects is an 294 outcome measure for successful AED therapy in people (Lee 2014) . Newer AEDs commonly 295 fail to show better efficacy than older AEDs. Thus, the selection of the first-line drug is mostly 296 lead by the characteristics and frequency of the AED side effects (Lee 2014) . With the advent 297 of newer AEDs in veterinary medicine AED side effects have the potential to drive drug 298 selection, given the perceived impact of the side effects on the QoL of the dog by the carer. 299
Despite multiple AEDs being available in human medicine, there remains a need for new AEDs 300 in canine and human epilepsy with fewer side effects, increased efficacy, drugs with different 301 mechanism of action with the potential of synergistic combination therapy (Lee 2014 This positive finding associated with IE is encouraging and may reflect an enhanced connection 323 between diseased pet and carer observed for cats with diabetes mellitus and their carers (Niessen 324 and others 2010). 325
326
This study showed on a large scale, that canine IE has not only an effect on the perceived QoL 327 of the affected dog but is also significantly associated with the carer's perceived QoL. Carers 328 reporting a decreased QoL in their dogs were more likely to report that their QoL had decreased 329 too. Seizure frequency, severity of AED side effects sleeping more and ataxia and dogs 330 15 receiving third line AEDs were associated with the carer perceived dog's QoL, with higher 331 severities predicting lower QoL scores. Thus, optimising seizure control and AED therapy will 332 not only affect the perceived QoL of the affected dog but also of the carer. The carer's QoL 333 affected by caring for an epileptic dog is an important part of IE treatment as the perceived 334 impact of IE not only on the dogs' but also on the carers' QoL is likely to influence a carer's 335 choices regarding treatment or euthanasia and requires consideration when treatment options 336 are discussed. 337 338 Table 1 . Impact of antiepileptic drug side effects upon carer perceived dog's quality of life 453 score. The factors 'drinking more', 'sleeping more', 'wobbly/not coordinated when walking' 454 and 'restlessness/pacing' were tested in a generalised linear mixed model (glmm) with breed 455 taken into account as a random effect. The severity of 'sleeping more' and the severity of being 456 'wobbly/not coordinated when walking' (p<0.050) significantly predicted carer perceived 457 dog's QoL. The less severely the dog is affected by 'sleeping more' or being 'wobbly/not 458 coordinated when walking', the higher the carer perceived dog's QoL score. 459 460
Risk factor
Sub-category Coefficient (95% CI)
SE t P value
Intercept -5.7 (4.5-6.9) 0.6 9.2 0.000
Sleeping more Side effect not present 1. 
